ENTPD1 and neoplasm: As indicated by TCR repertoire profiling in ovarian and colorectal cancers, only a minor fraction of CD8+ TILs are tumor-specific, while the majority consists of CD39− CD8+ “bystander” T cells [97, 103, 104].